Skip to main content
Standardized discharge orders after stroke: results of the quality improvement in stroke prevention (QUISP) cluster randomized trial.
Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis.
Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?
Status report: the Annals in 2010.
Interleukin-6 genotype and risk for cerebral palsy in term and near-term infants.
Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial.
Glutathione peroxidase activity modulates recovery in the injured immature brain.
Treatment of childhood arterial ischemic stroke.
Activated Src kinases interact with the N-methyl-D-aspartate receptor after neonatal brain ischemia.
Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial.